ISR 50 (Immune System Regulation AB)
N/A
Report date: 2026/03/04 20:01:44
NME
Base Information
Drug NameISR 50 (Immune System Regulation AB)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIsomerase Therapeutics
China Registration ClassN/A
Develop Information
Active CompaniesImmune System Regulation Ab
Inactive CompaniesN/A
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A